老年人可以从团结中受益吗? - 不同的单元化操作对与年龄相关的关联记忆缺陷的影响
Zejun Liu1, Yujuan Wang2, Zhu Yajun3
1School of Psychology, Shanghai Normal University, Shanghai, China; Lab for Educational Big Data and Policymaking, Ministry of Education, Shanghai Normal University, Shanghai, China.
Acta psychologica
|September 6, 2025
概括
年长的成年人经历了与年龄相关的关联性记忆缺陷. 统一化策略,特别是交互式图像,可以通过增强熟悉性和支持记忆结合来缓解这些缺陷.
科学领域:
- 认知神经科学
- 神经心理学
- 人类衰老的研究
背景情况:
- 老年人的关联记忆力下降, 这种现象被称为与年龄相关的关联记忆力缺陷.
- 关联性缺陷假设将这种下降与海马缩联系在一起,损害了信息结合和回忆.
- 统一化是增强信息结合和熟悉性的潜在策略,从而支持关联记忆.
研究的目的:
- 系统地调查各种单元化操作对与年龄相关的关联记忆缺陷的影响.
- 探索不同的单元化技术是否可以减轻老年人观察到的关联性记忆的下降.
- 阐明熟悉和回忆在与年龄相关的关联记忆中的作用以及对这些组件的统一化影响.
主要方法:
- 为了评估自下而上的和自上而下的统一化策略对年轻人和老年人的关联性记忆的影响,进行了三项实验.
- 参与者从事概念定义和交互图像等任务,以操纵单位化水平.
- 在实验条件下估计熟悉性和回忆对关联性记忆的贡献.
主要成果:
- 从底层向上对关联记忆的效果是通过单位化水平调节的,但并没有显著地缓解与年龄相关的缺陷.
- 一个概念定义任务加剧了与年龄相关的缺陷,而互动图像的自上而下的统一化减轻了它.
- 与年轻人相比,老年人记忆力显著下降,而熟悉性基本保持不变;统一化增强了基于熟悉性的关联性记忆支持.
结论:
- 统一化策略,尤其是交互式图像等自上而下的方法,有望缓解与年龄相关的关联记忆缺陷.
- 这些发现突显了回忆和熟悉性对老化中的关联性记忆的差异性贡献,熟悉性更有弹性.
- 这项研究提供了实验证据,支持统一化作为改善老年人关联记忆的可行干预措施.
相关概念视频
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
861
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
861
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
01:30Cognitive Development During Adulthood
1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21